课题基金 / 基金详情

项目摘要

项目成果

Lois Greene的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our laboratory is interested in the formation and dissolution of both normal and pathological protein complexes in the cell with an emphasis on the role of molecular chaperones in this process. We have continued our studies on endocytosis, examining what drives the assembly of the clathrin-coated pit. We previously showed that during, clathrin-mediated endocytosis, both clathrin and AP2 on clathrin-coated pits exchanged with free clathrin and AP2 in cells. To better understand the mechanism of clathrin and AP2 exchange, these processes were examined in a cell-free system. We found that Hsc70 was not only required for dissociation of clathrin but, in addition, by binding to the dissociated clathrin, it also facilitated the rebinding of clathrin to the pits. As for the exchange of AP2, we found that it was caused by a cycle of phosphorylation and dephosphorylation of the beta chain of AP2 with the former causing dissociation and the latter rebinding of AP2. Finally, we found that clathrin-coated pits were able to be regenerated by addition of cytosol provided that both PIP2 and a small nucleus of AP2 were present on the plasma membrane. In contrast, irreversible dissolution of the pits occurred upon complete dissociation of AP2 or a decrease in the PIP2 level. Aside from our research on clathrin-mediated endocytosis, we have focused on the propagation of prions, which are infective proteins having an amyloid conformation. In yeast, the molecular chaperone, Hsp104, regulates the inheritance of several yeast prions including PSI+, which is the prion form of the translation termination factor Sup35p. By using live cell imaging, we found that Sup35p-GFP in the non-prion form was diffuse in psi- cells, while Sup35p-GFP in prion-form was aggregated in PSI+ cells. To test whether these foci are the actual seeds or propagons, which are responsible for maintaining the prion phenotype, we examined whether the number of foci in yeast cells correlate with the extent of curing of PSI+ when yeast are cured by inactivation of Hsp104 using a dominant negative Hsp104 mutant. Imaging of the cells followed by plating showed there is a direct correlation between the number of cells with foci and the curing of the PSI+ phenotype. In addition, we re-examined the fluorescence changes that occur upon guanidine addition, which also cure PSI+ yeast by inactivating Hsp104. In agreement with our previous studies, we found in the presence of guanidine, there are no visible foci in yeast that are still PSI+. However, we now find that upon stress treatments, the foci become visible in these cells and show a direct correlation between the percentage of cells having foci and the extent of curing. Therefore, curing cells either using the dominant negative Hsp104 mutant or guanidine treatment to inactivated Hsp104 yield data that are consistent with a model in which inhibiting Hsp104 prevents the seeds or propagons from replicating and cell division is required for dilution of the remaining seeds or propagons to cure yeast of the prion phenotype. We also have been examining the trafficking of prion protein, both the native form and the amyloid form of the protein called scrapie, in mouse neuronal cell lines. Cells were depleted of clathrin using RNA interference to determine whether clathrin-mediated endocytosis was required for the internalization of prion protein. Our results showed that both the constitutive and copper-stimulated internalization of prion occurred via a clathrin-independent, dynamin-dependent pathway. Finally, to understand scrapie propagation, we have been examining the trafficking of the scrapie form of the prion protein through the endocytic pathway to the lysosome
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Letter to the editor: 1H, 15N, and 13C NMR backbone assignments and secondary structure of the C-terminal recombinant fragment of auxilin including the J-domain.
致编辑的信:辅助素 C 端重组片段(包括 J 结构域)的 1H、15N 和 13C NMR 主链分配和二级结构。
DOI: 10.1023/a:1008353226591
发表时间: 2000
期刊: Journal of biomolecular NMR
影响因子: 2.7
作者: [Han,CJ, Gruschus,JM, Greener,T, Greene,LE, Ferretti,J, Eisenberg,E]
通讯作者: Eisenberg,E
Exchange of clathrin, AP2 and epsin on clathrin-coated pits in permeabilized tissue culture cells.
透化组织培养细胞中网格蛋白包被的凹坑上网格蛋白、AP2 和 Epsin 的交换。
DOI: 10.1242/jcs.02356
发表时间: 2005
期刊: Journal of cell science
影响因子: 4
作者: [Yim,Yang-In, Scarselletta,Sarah, Zang,Fang, Wu,Xufeng, Lee,Dong-Won, Kang,Young-Shin, Eisenberg,Evan, Greene,LoisE]
通讯作者: Greene,LoisE
Expression of auxilin or AP180 inhibits endocytosis by mislocalizing clathrin: evidence for formation of nascent pits containing AP1 or AP2 but not clathrin.
辅助蛋白或 AP180 的表达通过使网格蛋白错误定位来抑制内吞作用:形成含有 AP1 或 AP2 但不含网格蛋白的新生凹坑的证据。
DOI: 10.1242/jcs.114.2.353
发表时间: 2001
期刊: Journal of cell science
影响因子: 4
作者: [Zhao,X, Greener,T, Al-Hasani,H, Cushman,SW, Eisenberg,E, Greene,LE]
通讯作者: Greene,LE
Curing of yeast [PSI+] prion by guanidine inactivation of Hsp104 does not require cell division.
通过 Hsp104 的胍灭活来治愈酵母 [PSI ] 朊病毒不需要细胞分裂。
DOI: 10.1073/pnas.0506384102
发表时间: 2005
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Wu,Yue-Xuan, Greene,LoisE, Masison,DanielC, Eisenberg,Evan]
通讯作者: Eisenberg,Evan
7
    Role of molecular chaperones in protein folding diseases
    Role of molecular chaperones in protein folding diseases
    70-kda Heat Shock Proteins And Their Associated Cofactors
    Role of molecular chaperones in protein folding diseases
    国内基金
    海外基金
    基于聚金属氧酸盐对Amyloid蛋白的定点化学修饰及其在阿尔茨海默症治疗中的应用
    • 批准号:
      22077118
    • 项目类别:
      面上项目
    • 资助金额:
      63.0万元
    • 批准年份:
      2020
    • 负责人:
      高楠
    • 依托单位:
    基于S1P通路探究Amyloid-β在干性年龄相关性黄斑变性中的作用
    • 批准号:
      81870666
    • 项目类别:
      面上项目
    • 资助金额:
      57.0万元
    • 批准年份:
      2018
    • 负责人:
      王海燕
    • 依托单位:
    Amyloid-beta-PirB 相互作用介导小胶质细胞表型和功能变化参与AD进展的机制研究
    • 批准号:
      81601123
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      17.0万元
    • 批准年份:
      2016
    • 负责人:
      都瑾
    • 依托单位:
    Beta-amyloid寡聚体特有的抗原表位多肽疫苗的研究
    • 批准号:
      30971012
    • 项目类别:
      面上项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2009
    • 负责人:
      刘瑞田
    • 依托单位: